You are here: Industry Insights > COVID-19

News List

IIT, BHU to re-purpose approved drugs from DrugBank database for treating COVID-19 expresspharma
June 04, 2020
The research group is working on developing new drug candidates against SARS-CoV-2 by exploring DrugBank database compounds as an inhibitor of SARS-CoV-2 main protease, a key enzyme required for SARS-CoV-2 assembly and multiplication.
Moleculin Provides Update on Coronavirus Drug Development americanpharmaceuticalreview
June 03, 2020
Moleculin Biotech announced the US Food and Drug Administration (FDA) has granted the Company's request for a Pre-IND Meeting to provide guidance regarding the Company's plan to study its drug candidate, WP1122 ...
I-Mab Release Results for Anti-GM-CSF Antibody TJM2 to Treat CRS-Related COVID-19 americanpharmaceuticalreview
June 03, 2020
I-Mab announced interim results from a multi-center, double blinded, randomized, placebo-controlled, three-arm clinical study of TJM2 in patients with cytokine release syndrome (CRS) associated with severe coronavirus disease 2019 (COVID-19).
Mass spectrometry identifies biomarkers of COVID-19 disease severity europeanpharmaceuticalreview
June 03, 2020
Researchers have identified 27 biomarkers that could be used to predict the course of SARS-CoV-2 infection and whether a patient with COVID-19 will become severely ill.
Simple but effective: an experimental nanoparticle COVID-19 test europeanpharmaceuticalreview
June 03, 2020
Researchers reveal their experimental test can detect the presence of COVID-19 RNA in a sample in 10 minutes, and in a way that does not require trained personnel to interpret.
Pharma industry welcomes Emergency Credit Line Guarantee Scheme expresspharma
June 03, 2020
In line with the guidelines of ECLGS, banks will be providing additional Working Capital Term Loan (WCTL) facility to the COVID-19 affected BEs/MSMEs.
Russia to roll out its first approved COVID-19 drug next week expresspharma
June 03, 2020
Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview.
Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients expresspharma
June 03, 2020
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials.
Indian pharma companies looking to leverage opportunities in drug repurposing: GlobalData expresspharma
June 03, 2020
The Drug Controller General of India (DCGI) has recently given approval to Indian pharma companies Glenmark and Strides Pharma Science to initiate clinical trials of favipiravir for COVID-19 patients.
Te Herenga Waka—Victoria University, NZ professor receives funding boost for vaccine research expresspharma
June 03, 2020
Te Herenga Waka—Victoria University of Wellington Associate Professor Bridget Stocker has received a significant funding boost for vaccine research that has potential to help with diseases ranging from bowel cancer to COVID-19.